These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35891446)

  • 1. Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors.
    Dinh LP; Sun J; Glenn CD; Patel K; Pigza JA; Donahue MG; Yet L; Kessl JJ
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.
    Sun J; Kessl JJ
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer.
    Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ
    J Biol Chem; 2021; 296():100363. PubMed ID: 33539919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.
    Feng L; Sharma A; Slaughter A; Jena N; Koh Y; Shkriabai N; Larue RC; Patel PA; Mitsuya H; Kessl JJ; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2013 May; 288(22):15813-20. PubMed ID: 23615903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of multimerization selective inhibitors of HIV-1 integrase.
    Sharma A; Slaughter A; Jena N; Feng L; Kessl JJ; Fadel HJ; Malani N; Male F; Wu L; Poeschla E; Bushman FD; Fuchs JR; Kvaratskhelia M
    PLoS Pathog; 2014 May; 10(5):e1004171. PubMed ID: 24874515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors.
    Koneru PC; Francis AC; Deng N; Rebensburg SV; Hoyte AC; Lindenberger J; Adu-Ampratwum D; Larue RC; Wempe MF; Engelman AN; Lyumkis D; Fuchs JR; Levy RM; Melikyan GB; Kvaratskhelia M
    Elife; 2019 May; 8():. PubMed ID: 31120420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.
    Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
    Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
    ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.
    Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E
    J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.
    Shkriabai N; Dharmarajan V; Slaughter A; Kessl JJ; Larue RC; Feng L; Fuchs JR; Griffin PR; Kvaratskhelia M
    J Biol Chem; 2014 Sep; 289(38):26430-26440. PubMed ID: 25118283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
    Gupta K; Turkki V; Sherrill-Mix S; Hwang Y; Eilers G; Taylor L; McDanal C; Wang P; Temelkoff D; Nolte RT; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
    PLoS Biol; 2016 Dec; 14(12):e1002584. PubMed ID: 27935939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome.
    van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B
    PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.
    Deng N; Hoyte A; Mansour YE; Mohamed MS; Fuchs JR; Engelman AN; Kvaratskhelia M; Levy R
    Protein Sci; 2016 Nov; 25(11):1911-1917. PubMed ID: 27503276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole-based allosteric inhibitors of HIV-1 integrase.
    Patel PA; Kvaratskhelia N; Mansour Y; Antwi J; Feng L; Koneru P; Kobe MJ; Jena N; Shi G; Mohamed MS; Li C; Kessl JJ; Fuchs JR
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4748-4752. PubMed ID: 27568085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.
    Dinh T; Tber Z; Rey JS; Mengshetti S; Annamalai AS; Haney R; Briganti L; Amblard F; Fuchs JR; Cherepanov P; Kim K; Schinazi RF; Perilla JR; Kim B; Kvaratskhelia M
    mBio; 2024 Nov; 15(11):e0046524. PubMed ID: 39404354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a Distinct Chemical and Mechanistic Class of Allosteric HIV-1 Integrase Inhibitors with Antiretroviral Activity.
    Burlein C; Wang C; Xu M; Bhatt T; Stahlhut M; Ou Y; Adam GC; Heath J; Klein DJ; Sanders J; Narayan K; Abeywickrema P; Heo MR; Carroll SS; Grobler JA; Sharma S; Diamond TL; Converso A; Krosky DJ
    ACS Chem Biol; 2017 Nov; 12(11):2858-2865. PubMed ID: 29024587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.
    Slaughter A; Jurado KA; Deng N; Feng L; Kessl JJ; Shkriabai N; Larue RC; Fadel HJ; Patel PA; Jena N; Fuchs JR; Poeschla E; Levy RM; Engelman A; Kvaratskhelia M
    Retrovirology; 2014 Nov; 11():100. PubMed ID: 25421939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activity.
    Wang C; Adam GC; Burlein C; Carroll S; Dankulich W; Diamond T; Grobler J; Heath J; Johnson A; Klein D; Krosky D; Narayan K; Ou Y; Sanders J; Sharma S; Xu M; Converso A
    Bioorg Med Chem Lett; 2023 Jun; 89():129303. PubMed ID: 37146837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors.
    Singh PK; Li W; Bedwell GJ; Fadel HJ; Poeschla EM; Engelman AN
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitors.
    Parcella K; Patel M; Tu Y; Eastman K; Peese K; Gillis E; Belema M; Dicker IB; McAuliffe B; Ding B; Falk P; Simmermacher J; Parker DD; Sivaprakasam P; Khan JA; Kish K; Lewis H; Hanumegowda U; Jenkins S; Kadow JF; Krystal M; Meanwell NA; Naidu BN
    Bioorg Med Chem; 2022 Aug; 67():116833. PubMed ID: 35605346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.